Iksuda Therapeutics
PrivateLast Round
Strategic
Jun 15, 2025
Est. Valuation
$93.98M
Total Funding Raised
$68.75M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Iksuda Therapeutics is a clinical-stage biotechnology company that specializes in the development of next-generation Antibody-Drug Conjugates (ADCs) for treating cancers with high unmet needs.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Iksuda Therapeutics Comparables
Compare Iksuda Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| MediLink Therapeutics | 83% | |
| Sutro Biopharma Inc | 82% | |
| Duality Biotherapeutics Inc | 80% | |
Iksuda Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Jun 15, 2025 | ||||
| Corporate Funding | Mar 21, 2025 | ||||
| Strategic | Nov 15, 2024 | ||||
| Series A | Jun 7, 2021 | ||||
| Grant | Jun 6, 2017 | ||||
Grant | Jul 27, 2015 |
Iksuda Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| LigaChem Biosciences | Corporate Funding, Strategic |
| IP Group | Series A, Seed |
| North East Access to Finance | Seed |
| Premier Partners | Series A |
| Mirae Asset Securities | Series A |
| Centre for Process Innovation | Grant |
| Innovate UK | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors grew 41% MoM, reaching 2.8K.
- Jan 8, 2026
Presenting data at the 2026 ASCO Gastrointestinal Cancers Symposium in San Francisco.
Iksuda Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Iksuda Therapeutics's valuation, stock price, and market status.